Form 8-K - Current report:
SEC Accession No. 0001640334-25-000087
Filing Date
2025-01-15
Accepted
2025-01-15 12:02:12
Documents
15
Period of Report
2025-01-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lxrp_8k.htm   iXBRL 8-K 61882
  Complete submission text file 0001640334-25-000087.txt   203270

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lxrp-20250114.xsd EX-101.SCH 6102
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lxrp-20250114_lab.xml EX-101.LAB 16261
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lxrp-20250114_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lxrp-20250114_pre.xml EX-101.PRE 11938
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lxrp-20250114_def.xml EX-101.DEF 4194
17 EXTRACTED XBRL INSTANCE DOCUMENT lxrp_8k_htm.xml XML 5593
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-39874 | Film No.: 25532179
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)